Loomis, Sayles & Company Portfolio holdings
AUM
$79.8B
1-Year Return
31.99%
This Quarter Return
+10.76%
1 Year Return
+31.99%
3 Year Return
+166.63%
5 Year Return
+219.21%
10 Year Return
+619.03%
AUM
$82.5B
AUM Growth
+$5.26B
(+6.8%)
Cap. Flow
-$2.04B
Cap. Flow
% of AUM
-2.48%
Top 10 Holdings %
Top 10 Hldgs %
38.94%
Holding
962
New
128
Increased
342
Reduced
292
Closed
135
Top Buys
| 1 |
Vertex Pharmaceuticals
VRTX
|
$413M |
| 2 |
Airbnb
ABNB
|
$230M |
| 3 |
T-Mobile US
TMUS
|
$163M |
| 4 |
Alnylam Pharmaceuticals
ALNY
|
$160M |
| 5 |
CRISPR Therapeutics
CRSP
|
$147M |
Top Sells
| 1 |
Deere & Co
DE
|
$472M |
| 2 |
Bristol-Myers Squibb
BMY
|
$228M |
| 3 |
Expeditors International
EXPD
|
$205M |
| 4 |
Qualcomm
QCOM
|
$198M |
| 5 |
Meta Platforms (Facebook)
META
|
$177M |
Sector Composition
| 1 | Technology | 26.12% |
| 2 | Consumer Discretionary | 15.99% |
| 3 | Communication Services | 13.72% |
| 4 | Healthcare | 12.84% |
| 5 | Industrials | 11.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
201
Rocket Pharmaceuticals
RCKT
$354M
| $39.8M | 0.05% |
899,510
-18,214
| -2% | -$807K |
|
202
Newmont
NEM
$83.7B
| $39.1M | 0.05% |
616,844
-165,444
| -21% | -$10.5M |
|
203
BioMarin Pharmaceuticals
BMRN
$11.1B
| $38.4M | 0.05% |
460,073
-55,826
| -11% | -$4.66M |
|
204
Nomad Foods
NOMD
$2.21B
| $38.3M | 0.05% |
1,353,863
+25,022
| +2% | +$707K |
|
205
PTC Therapeutics
PTCT
$4.55B
| $38.3M | 0.05% |
904,917
+1,951
| +0.2% | +$82.5K |
|
206
SM Energy
SM
$3.09B
| $38.2M | 0.05% |
+1,551,312
| New | +$38.2M |
|
207
Replimune Group
REPL
$494M
| $38.1M | 0.05% |
992,593
+215,411
| +28% | +$8.28M |
|
208
Arcosa
ACA
$4.79B
| $38.1M | 0.05% |
649,064
-3,541
| -0.5% | -$208K |
|
209
Globus Medical
GMED
$8.18B
| $38M | 0.05% |
490,138
+19,285
| +4% | +$1.5M |
|
210
Floor & Decor
FND
$9.42B
| $37.7M | 0.05% |
356,795
+14,043
| +4% | +$1.48M |
|
211
Champion Homes, Inc.
SKY
$4.43B
| $37.2M | 0.05% |
698,461
+15,733
| +2% | +$839K |
|
212
Paylocity
PCTY
$9.62B
| $36.8M | 0.04% |
193,071
+7,585
| +4% | +$1.45M |
|
213
SI-BONE Inc
SIBN
$703M
| $36.6M | 0.04% |
1,164,188
+302,551
| +35% | +$9.52M |
|
|
SYNH
214
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $36.6M | 0.04% |
408,975
+16,144
| +4% | +$1.44M |
|
215
Morningstar
MORN
$10.8B
| $36.2M | 0.04% |
140,920
+5,524
| +4% | +$1.42M |
|
216
Nova
NVMI
$7.58B
| $36.1M | 0.04% |
350,463
+13,780
| +4% | +$1.42M |
|
217
Home BancShares
HOMB
$5.88B
| $35.8M | 0.04% |
1,449,828
+76,754
| +6% | +$1.89M |
|
218
Oxford Industries
OXM
$629M
| $35.6M | 0.04% |
+360,101
| New | +$35.6M |
|
219
Vontier
VNT
$6.37B
| $35.4M | 0.04% |
1,086,314
+99,132
| +10% | +$3.23M |
|
220
Valvoline
VVV
$4.96B
| $35.2M | 0.04% |
1,083,357
+3,719
| +0.3% | +$121K |
|
|
BPMC
221
DELISTED
Blueprint Medicines
BPMC
| $34.8M | 0.04% |
395,368
-8,034
| -2% | -$707K |
|
222
Generac Holdings
GNRC
$10.6B
| $34.5M | 0.04% |
83,155
-26,535
| -24% | -$11M |
|
223
Trimble
TRMB
$19.2B
| $33.8M | 0.04% |
413,359
-128,507
| -24% | -$10.5M |
|
224
Inogen
INGN
$219M
| $33.6M | 0.04% |
+515,451
| New | +$33.6M |
|
225
Semtech
SMTC
$5.26B
| $33.2M | 0.04% |
483,112
+19,006
| +4% | +$1.31M |
|